Messenger RNA (mRNA) Vaccines and Therapeutics Market in United States, United Kingdom– Market Outlook, Market Assessment and Market Forecast (2023-2030)

1. Executive Summary: Messenger RNA (mRNA) Vaccines and Therapeutics
   • Global Market Outlook: Messenger RNA (mRNA) Vaccines and Therapeutics
2. Competitive Intelligence Analysis; Messenger RNA (mRNA) Vaccines and Therapeutics
3. Therapeutic Sector SWOT
4. Technology Roadmap Analysis
5. Market Background
   • Drivers
   • Restraints
   • Opportunity
   • Key Market Trends
   • Key Unmet Needs
6. Messenger RNA (mRNA) Vaccines and Therapeutics: Key Marketed Products Profile – Major Approved Products
   • Product Profile
   • Regulatory Milestones
   • Safety and Efficacy
   • Clinical Development
7. Messenger RNA (mRNA) Vaccines and Therapeutics: Promising Pipeline Candidates – Major Products in Late Stage of Development
   • Product Description
   • Safety and Efficacy
   • Research and Development
8. Regulatory Landscape
9. Messenger RNA (mRNA) Vaccines and Therapeutics: Eight Major Market (8MM) – Market Analysis
   • Historical Market Analysis (US$ million), 2020-2022
   • Current and Future Market Projections (US$ million), 2023-2030
10. S. Messenger RNA (mRNA) Vaccines and Therapeutics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
    • Current and Future Market Projections (US$ million), 2023-2030
11. K. Messenger RNA (mRNA) Vaccines and Therapeutics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
    • Current and Future Market Projections (US$ million), 2023-2030
12. Germany Messenger RNA (mRNA) Vaccines and Therapeutics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
    • Current and Future Market Projections (US$ million), 2023-2030
13. France Messenger RNA (mRNA) Vaccines and Therapeutics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
    • Current and Future Market Projections (US$ million), 2023-2030
14. Italy Messenger RNA (mRNA) Vaccines and Therapeutics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
    • Current and Future Market Projections (US$ million), 2023-2030
15. Spain Messenger RNA (mRNA) Vaccines and Therapeutics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
    • Current and Future Market Projections (US$ million), 2023-2030
16. Japan Messenger RNA (mRNA) Vaccines and Therapeutics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
    • Current and Future Market Projections (US$ million), 2023-2030
17. China Messenger RNA (mRNA) Vaccines and Therapeutics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
    • Current and Future Market Projections (US$ million), 2023-2030
18. Competitive Landscape
    • Company Overview
    • Product Portfolio
    • Key Financials
    • Sales Footprint

Note – All Major Company Profiles (Count up to 20) will be covered in the report

19. Assumptions and Acronyms Used
20. Research Methodology
    • Secondary Research
    • Primary Research
    • Data Triangulation
21. Geographic Scope
    • The U.S., The U.K., Germany, France, Italy, Spain, Japan, and China
22. Copyrights and Disclaimer

Messenger RNA (mRNA) Vaccines and Therapeutics – Report Overview

Pacific Business Consulting’s “Messenger RNA (mRNA) Vaccines and Therapeutics Market in 8MM – Market Outlook, Market Assessment and Market Forecast (2023-2030)” report offers a comprehensive exploration of Messenger RNA (mRNA) Vaccines and Therapeutics market, encompassing historical and projected market size data, along with market trends, market drivers, market barriers and unmet medical needs in the Eight Major Markets (8MM) of the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and China.

The mRNA therapeutics market, valued at US$ 35.4 Billion in 2022, is expected to exhibit a compound annual growth rate (CAGR) of nearly 2% between 2023 and 2030. RNA-based therapeutics, particularly mRNA vaccines, have gained significant attention for their potential in treating chronic diseases. RNA vaccines offer advantages over DNA vaccines in terms of production, distribution, and safety. The success of mRNA vaccines against COVID-19 from companies like Moderna and Pfizer-BioNTech has increased demand for mRNA vaccines and therapeutics. Notably, the number of mRNA-based vaccine therapeutics in oncology clinical trials has significantly expanded, particularly in the aftermath of successful COVID-19 trials, making 2021-2022 the period with the second-highest number of mRNA vaccine trials for cancer patients.

Recent technological advancements, such as improved stability, translation, and delivery techniques, have positioned messenger RNAs as a promising therapeutic tool. mRNA vaccines, in particular, have opened new avenues in vaccine development, supporting next-generation vaccinations.

Companies and academics are actively engaged in assessing challenges and exploring opportunities in Messenger RNA (mRNA) Vaccines and Therapeutics research and development. Therapies under development focus on novel approaches to treat and improve disease conditions.

Key players in this market, including Moderna, Inc., BioNTech SE, AstraZeneca plc., CRISPR Therapeutics AG, Arcturus Therapeutics, Translate Bio, Inc., Sangamo Therapeutics, Inc., GSK plc., Argos Therapeutics Inc., and Pfizer Inc., are contributing to the advancement of global mRNA-based Vaccines and Therapeutics.

As awareness of diseases increases and healthcare spending rises globally, the Messenger RNA (mRNA) Vaccines and Therapeutics market is expected to undergo significant changes in the coming years. This shift is anticipated to expand the market size, enabling drug manufacturers to further penetrate the market.

Scope of Report

The report addresses critical subjects such as strategic competitor evaluation, market characterization, unmet needs, and the consequences of these elements for the Messenger RNA (mRNA) Vaccines and Therapeutics market. It also delves into the analysis of present and prospective market competition within the global Messenger RNA (mRNA) Vaccines and Therapeutics market.

Furthermore, the report offers an insightful examination of the primary industry drivers, constraints, and challenges. Each trend undergoes independent research to furnish qualitative analysis regarding its implications.

Reasons to Buy

• Develop your business strategies by gaining insights into the trends that shape and drive the Messenger RNA (mRNA) Vaccines and Therapeutics market across the 8MM (Eight Major Markets).
• Increase revenue by comprehending key trends, innovative products and technologies, market segments, and companies poised to influence the future of the 8MM Messenger RNA (mRNA) Vaccines and Therapeutics market.
• Craft effective sales and marketing strategies by thoroughly understanding the competitive landscape and analyzing the performance of various competitors.
• Identify emerging players with potentially robust product portfolios and devise strategic counter-strategies to gain a competitive advantage.
• Optimize your sales and marketing efforts by pinpointing market categories and segments that offer the greatest opportunities for consolidations, investments, and strategic partnerships.

Please note that detailed pipeline analysis can be provided along with the standard scope to assist you in developing and designing your in-licensing and out-licensing strategies. This includes a review of pipeline products and technologies, along with identifying companies with the most robust pipeline.